Berliner Boersenzeitung - US researchers seek to legitimize AI mental health care

EUR -
AED 4.243598
AFN 76.263586
ALL 93.252722
AMD 423.077847
AOA 1060.756747
ARS 1729.009179
AUD 1.63715
AWG 2.082804
AZN 1.965146
BAM 1.957373
BBD 2.326069
BDT 142.954868
BHD 0.435742
BIF 3457.859125
BMD 1.155508
BND 1.48089
BOB 14.025967
BRL 5.938617
BSD 1.154928
BTN 109.794748
BWP 15.661517
BYN 3.415745
BYR 22647.966202
BZD 2.322716
CAD 1.618749
CDF 2612.604653
CHF 0.93223
CLF 0.026748
CLP 1056.157931
CNY 7.799775
CNH 7.796366
COP 3677.625283
CRC 523.720823
CUC 1.155508
CUP 30.620975
CVE 110.577359
CZK 24.184522
DJF 205.35721
DKK 7.475388
DOP 67.30804
DZD 153.466204
EGP 57.550907
ERN 17.332627
ETB 184.823403
FJD 2.553308
FKP 0.858801
GBP 0.857994
GEL 3.021622
GGP 0.858801
GHS 13.548336
GIP 0.858801
GMD 84.931759
GNF 10148.261152
GTQ 8.809078
GYD 241.584711
HKD 9.063364
HNL 31.036971
HRK 7.533572
HTG 151.001333
HUF 361.860769
IDR 20659.336108
ILS 3.470858
IMP 0.858801
INR 109.864533
IQD 1514.293863
IRR 1588593.057877
ISK 141.815325
JEP 0.858801
JMD 183.527469
JOD 0.819276
JPY 182.208653
KES 149.488533
KGS 101.048565
KHR 4682.700886
KMF 493.401915
KRW 1644.196411
KWD 0.357306
KYD 0.962469
KZT 541.953128
LAK 26120.269022
LBP 103475.784612
LKR 387.551407
LRD 209.436313
LSL 18.846604
LTL 3.411917
LVL 0.698955
LYD 7.354819
MAD 10.762117
MDL 20.066037
MGA 4971.568067
MKD 61.524919
MMK 2425.761657
MNT 4157.747973
MOP 9.330357
MRU 46.312797
MUR 54.285874
MVR 17.852389
MWK 2007.117959
MXN 19.919233
MYR 4.724922
MZN 73.848488
NAD 18.858
NGN 1574.334577
NIO 42.504153
NOK 11.010667
NPR 175.672918
NZD 1.962891
OMR 0.444286
PAB 1.154903
PEN 3.9114
PGK 5.111391
PHP 70.137026
PKR 321.001615
PLN 4.301566
PYG 6887.534304
QAR 4.212695
RON 5.246245
RSD 117.344628
RUB 93.568896
RWF 1693.975431
SAR 4.336079
SBD 9.323045
SCR 16.772158
SDG 693.886139
SEK 10.959647
SGD 1.480021
SLE 28.422197
SOS 693.885368
SRD 43.525699
STD 23916.692567
STN 24.843432
SVC 10.10512
SZL 18.846478
THB 38.224452
TJS 10.659434
TMT 4.04428
TND 3.367128
TRY 54.991339
TTD 7.834295
TWD 37.299582
TZS 3062.095139
UAH 51.681828
UGX 4307.461152
USD 1.155508
UYU 46.437314
UZS 13790.993709
VES 871.497494
VND 30333.2531
VUV 138.157226
WST 3.162341
XAF 656.481659
XAG 0.018569
XAU 0.000271
XCD 3.122819
XCG 2.081381
XDR 0.817469
XOF 656.91048
XPF 119.331742
YER 273.71111
ZAR 18.847672
ZMK 10400.959138
ZMW 22.046238
ZWL 372.073259
  • RBGPF

    -1.2500

    69.74

    -1.79%

  • CMSC

    -0.0600

    21.73

    -0.28%

  • CMSD

    0.0200

    22.04

    +0.09%

  • BTI

    0.1500

    59.27

    +0.25%

  • NGG

    -0.1600

    80.26

    -0.2%

  • GSK

    -0.0700

    51.46

    -0.14%

  • BCC

    -1.6900

    84.8

    -1.99%

  • RIO

    2.5000

    101.51

    +2.46%

  • BCE

    0.0600

    22.06

    +0.27%

  • BP

    -1.2300

    41.21

    -2.98%

  • RELX

    -0.1900

    36.61

    -0.52%

  • JRI

    -0.0500

    12.67

    -0.39%

  • RYCEF

    0.6500

    21

    +3.1%

  • AZN

    5.8800

    161.5

    +3.64%

  • VOD

    -0.3800

    15.31

    -2.48%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: Scott Eisen - GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

(H.Schneide--BBZ)